Literature DB >> 11195993

Biases in eye movements to threatening facial expressions in generalized anxiety disorder and depressive disorder.

K Mogg1, N Millar, B P Bradley.   

Abstract

The study investigated biases in selective attention to emotional face stimuli in generalized anxiety disorder (GAD) and depressive disorder, using a modified probe detection task. There were 4 face types: threatening, sad, happy, and neutral. Measures of attentional bias included (a) the direction and latency of the initial eye movement in response to the faces and (b) manual reaction time (RT) to probes replacing the face stimuli 1,000 ms after their onset. Results showed that individuals with GAD (without depressive disorder) were more likely to look first toward threat faces rather than neutral faces compared with normal controls and those with depressive disorder. They also shifted their gaze more quickly toward threat faces, rather than away from them, relative to the other two groups. There were no significant findings from the manual RT data. Implications of the results for recent theories of clinical anxiety and depression are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 11195993     DOI: 10.1037//0021-843x.109.4.695

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  99 in total

1.  The influence of emotional stimuli on attention orienting and inhibitory control in pediatric anxiety.

Authors:  Sven C Mueller; Michael G Hardin; Karin Mogg; Valerie Benson; Brendan P Bradley; Marie Louise Reinholdt-Dunne; Simon P Liversedge; Daniel S Pine; Monique Ernst
Journal:  J Child Psychol Psychiatry       Date:  2012-03-12       Impact factor: 8.982

2.  Attentional biases for emotional faces in young children of mothers with chronic or recurrent depression.

Authors:  Autumn J Kujawa; Dana Torpey; Jiyon Kim; Greg Hajcak; Suzanne Rose; Ian H Gotlib; Daniel N Klein
Journal:  J Abnorm Child Psychol       Date:  2011-01

Review 3.  Neurocognitive mechanisms of gaze-expression interactions in face processing and social attention.

Authors:  Reiko Graham; Kevin S Labar
Journal:  Neuropsychologia       Date:  2012-01-24       Impact factor: 3.139

4.  Inhalation of 7.5% carbon dioxide increases threat processing in humans.

Authors:  Matthew Garner; Angela Attwood; David S Baldwin; Alexandra James; Marcus R Munafò
Journal:  Neuropsychopharmacology       Date:  2011-04-13       Impact factor: 7.853

Review 5.  Triadic model of the neurobiology of motivated behavior in adolescence.

Authors:  Monique Ernst; Daniel S Pine; Michael Hardin
Journal:  Psychol Med       Date:  2006-03       Impact factor: 7.723

6.  Negative affectivity, effortful control, and attention to threat-relevant stimuli.

Authors:  Christopher J Lonigan; Michael W Vasey
Journal:  J Abnorm Child Psychol       Date:  2009-04

7.  Fear of negative evaluation and the hypervigilance-avoidance hypothesis: an eye-tracking study.

Authors:  Matthias J Wieser; Paul Pauli; Peter Weyers; Georg W Alpers; Andreas Mühlberger
Journal:  J Neural Transm (Vienna)       Date:  2008-08-09       Impact factor: 3.575

8.  Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder.

Authors:  Christopher S Monk; Eva H Telzer; Karin Mogg; Brendan P Bradley; Xiaoqin Mai; Hugo M C Louro; Gang Chen; Erin B McClure-Tone; Monique Ernst; Daniel S Pine
Journal:  Arch Gen Psychiatry       Date:  2008-05

9.  Snake fearfulness is associated with sustained competitive biases to visual snake features: hypervigilance without avoidance.

Authors:  Menton McGinnis Deweese; Margaret M Bradley; Peter J Lang; Søren K Andersen; Matthias M Müller; Andreas Keil
Journal:  Psychiatry Res       Date:  2014-06-02       Impact factor: 3.222

Review 10.  Worry and generalized anxiety disorder: a review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment.

Authors:  Michelle G Newman; Sandra J Llera; Thane M Erickson; Amy Przeworski; Louis G Castonguay
Journal:  Annu Rev Clin Psychol       Date:  2013       Impact factor: 18.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.